Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
The release of generic versions of brand name drugs for patients with multiple sclerosis had little overall effect on the price increase.
[[thumbnail_alt_text]]
The diazepam nasal spray was granted 7 years of Orphan Drug Exclusivity by the FDA Office of Orphan Products Development.
[[thumbnail_alt_text]]
Patients with epilepsy treated with perampanel during routine clinical care had favorable retention rates and sustained efficacy.
[[thumbnail_alt_text]]
An analysis of efficacy and safety outcomes in patients receiving perampanel as first adjunctive antiepileptic drug found that almost half of the patients were seizure-free.
[[thumbnail_alt_text]]
In this study, researchers wanted to evaluate the frequency of reduced immunoglobulin concentrations and its association with immunotherapy and disease course in 2 independent cohorts with multiple sclerosis.
[[thumbnail_alt_text]]
Fingolimod treats relapsing forms of multiple sclerosis in adult patients.
[[thumbnail_alt_text]]
Riluzole oral film (Exservan, Aquestive Therapeutics) has received early-action approval from the FDA for the treatment of amyotrophic lateral sclerosis.
[[thumbnail_alt_text]]
Approved by the FDA in May 2019, midazolam nasal spray CIV (Nayzilam, UCB) is the first nasal rescue treatment for seizure clusters in the United States.
[[thumbnail_alt_text]]
If approved, risdiplam (Genentech) would be the first at-home administered medicine for patients living with spinal muscular atrophy.
 
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
 
[[thumbnail_alt_text]]
Officials with the FDA have approved adalimumab-afzb (Abrilada, Pfizer), a biosimilar to Humira, for the treatment of certain patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn disease, ulcerative colitis, and plaque psoriasis.
[[thumbnail_alt_text]]
Cenobamate is an investigational antiepileptic drug that has shown broad spectrum anticonvulsant activity in preclinical studies and seizure models.